Diagnos Laboratorium Utama Tbk. vs Midi Utama Indonesia Tbk. — how do they compare? Diagnos Laboratorium Utama Tbk. trades at Rp224 (market cap 310.75B, 963.6K 24h volume), while Midi Utama Indonesia Tbk. trades at Rp284 (market cap 9.43T, 2.81M 24h volume). The key difference: Midi Utama Indonesia Tbk. is far larger — about 30.3× Diagnos Laboratorium Utama Tbk.'s market cap, and Midi Utama Indonesia Tbk. is more actively traded (2.81M versus 963.6K). Which is the better fit depends on your goals.
| DGNS | MIDI | |
|---|---|---|
Market Cap | 310.75B | 9.43T |
Volume | 963.6K | 2.81M |
Lot | 9.64K | 28.1K |
Turnover | 217.67M | 788.78M |
Average Price | 225.89 | 280.71 |
Value | 217.67M | 788.78M |
Indicative Equilibrium Price | 226 | 284 |
Indicative Equilibrium Volume | 1K | 155 |
Trailing returns across standard periods
Latest headlines on both assets
PT Diagnos Laboratorium Utama Tbk (the “Company”) was established in the Republic of Indonesia on August 29, 2007 under framework of the Domestic Capital Investment Law No. 6 Year 1968 based on Deed No.17 dated August 29, 2007, of Martinef, S.H., M.Si., Notary in Bekasi. The Company started its commercial operation in 2008.
Read more on DGNS →PT Midi Utama Indonesia (the company) was established under its original name of PT Midimart Utama base on notarial deed No.37 of Mr Frans Elsius, S.H, dated on 28 Jun, 2007. The Company’s articles of association has been amended several times, most recently by notarial deed No. 2 of Kamelina, S.H., dated Mar 3, 2010, concerning among others, increase in capital paid up and public offering.
Read more on MIDI →